INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44h ago
HOUSE PTR4h ago
SEC 13F4h ago
ROBINHOOD CHAIN4h ago
Public company

TRAWTraws Pharma, Inc.

CIK 0001130598

EDGAR filingsOpen in network
Disclosed transactions16
Buys / sells0 / 0
Max Insider Score24
Connections6with evidence

TRAW · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
24
PN
Parker Charles NolanChief Financial Officer
TRAWTraws Pharma, Inc.
Grant or award
A—
15.4K sh
Dec 12, 2025Apr 8, 2026
traded Dec 12, 2025
+117dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Parker Charles NolanChief Financial Officer · Apr 8, 2026
  • ← Insider ofevidence
    Clarke TraffordDirector · Dec 16, 2025
  • ← Insider ofevidence
    Redfield RobertChief Medical Officer · Dec 16, 2025
19
PN
Parker Charles NolanChief Financial Officer
TRAWTraws Pharma, Inc.
Grant or award
A
—
104.5K sh
Mar 8, 2026
Apr 8, 2026
traded Mar 8, 2026
+31d
SEC FORM 4

Evidence

24
PN
Parker Charles NolanChief Financial Officer
TRAWTraws Pharma, Inc.
Grant or award
A—
61.6K sh
Dec 12, 2025Apr 8, 2026
traded Dec 12, 2025
+117dSEC FORM 4

Evidence

24
PN
Parker Charles NolanChief Financial Officer
TRAWTraws Pharma, Inc.
Grant or award
A—
32.4K sh
Oct 12, 2025Apr 8, 2026
traded Oct 12, 2025
+178dSEC FORM 4

Evidence

9
SN
Savchuk NikolayDirector, Chief Operating Officer
TRAWTraws Pharma, Inc.
Grant or award
A—
96.9K sh
Mar 8, 2026Mar 10, 2026
traded Mar 8, 2026
+2dSEC FORM 4

Evidence

9
CT
Clarke TraffordDirector
TRAWTraws Pharma, Inc.
Grant or award
A—
33.4K sh
Mar 8, 2026Mar 10, 2026
traded Mar 8, 2026
+2dSEC FORM 4

Evidence

9
RR
Redfield RobertChief Medical Officer
TRAWTraws Pharma, Inc.
Grant or award
A—
108.9K sh
Mar 8, 2026Mar 10, 2026
traded Mar 8, 2026
+2dSEC FORM 4

Evidence

9
PD
Pauza Charles DavidChief Science Officer Virology
TRAWTraws Pharma, Inc.
Grant or award
A—
118.4K sh
Mar 8, 2026Mar 10, 2026
traded Mar 8, 2026
+2dSEC FORM 4

Evidence

13
RR
Redfield RobertChief Medical Officer
TRAWTraws Pharma, Inc.
Grant or award
A—
16.4K sh
Dec 12, 2025Dec 16, 2025
traded Dec 12, 2025
+4dSEC FORM 4

Evidence

13
SN
Savchuk NikolayDirector, Chief Operating Officer
TRAWTraws Pharma, Inc.
Grant or award
A—
16.4K sh
Dec 12, 2025Dec 16, 2025
traded Dec 12, 2025
+4dSEC FORM 4

Evidence

9
PD
Pauza Charles DavidChief Science Officer Virology
TRAWTraws Pharma, Inc.
Grant or award
A—
73.9K sh
Dec 12, 2025Dec 16, 2025
traded Dec 12, 2025
+4dSEC FORM 4

Evidence

13
PD
Pauza Charles DavidChief Science Officer Virology
TRAWTraws Pharma, Inc.
Grant or award
A—
18.5K sh
Dec 12, 2025Dec 16, 2025
traded Dec 12, 2025
+4dSEC FORM 4

Evidence

9
RR
Redfield RobertChief Medical Officer
TRAWTraws Pharma, Inc.
Grant or award
A—
65.7K sh
Dec 12, 2025Dec 16, 2025
traded Dec 12, 2025
+4dSEC FORM 4

Evidence

9
SN
Savchuk NikolayDirector, Chief Operating Officer
TRAWTraws Pharma, Inc.
Grant or award
A—
65.7K sh
Dec 12, 2025Dec 16, 2025
traded Dec 12, 2025
+4dSEC FORM 4

Evidence

9
CT
Clarke TraffordDirector
TRAWTraws Pharma, Inc.
Grant or award
A—
6,157 sh
Dec 12, 2025Dec 16, 2025
traded Dec 12, 2025
+4dSEC FORM 4

Evidence

9
CT
Clarke TraffordDirector
TRAWTraws Pharma, Inc.
Grant or award
A—
24.6K sh
Dec 12, 2025Dec 16, 2025
traded Dec 12, 2025
+4dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Pauza Charles DavidChief Science Officer Virology · Dec 16, 2025
  • ← Insider ofevidence
    Savchuk NikolayDirector, Chief Operating Officer · Dec 16, 2025